GlaxoSmithKline Pharma reports 33% fall in Q3 net profit

13 Feb 2017 Evaluate

GlaxoSmithKline Pharmaceuticals has reported results for third quarter ended December 31, 2016. 

The company has reported 32.92% fall in its net profit at Rs 52.95 crore for the quarter under review as compared to Rs 78.93 crore for the same quarter in the previous year. Total income of the company decreased by 7.21% at Rs 721.15 crore for the quarter under review as compared Rs 777.16 crore for the corresponding quarter previous year.

GlaxoSmithKline Pharmaceuticals is a subsidiary of GlaxoSmithKline plc, one of the world's leading research-based pharmaceutical and healthcare companies, committed to improving the quality of human life by enabling people to do more, feel better and live longer.  

Glaxosmithkline Phar Share Price

2598.00 -25.95 (-0.99%)
12-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1794.30
Dr. Reddys Lab 1279.65
Cipla 1517.20
Zydus Lifesciences 929.05
Lupin 2114.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×